| scholarly article | Q13442814 |
| P2093 | author name string | S Patel | |
| D B Rifkin | |||
| R L Shapiro | |||
| C J Ren | |||
| P Mignatti | |||
| G Pintucci | |||
| A C Galloway | |||
| G Seghezzi | |||
| A Gualandris | |||
| E S Robbins | |||
| P2860 | cites work | Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis | Q71563623 |
| Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms | Q71656434 | ||
| Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea | Q71695973 | ||
| A strategy to discover circulating angiogenesis inhibitors generated by human tumors | Q71709815 | ||
| Vascular endothelial growth factor administration in chronic myocardial ischemia | Q71800641 | ||
| Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia | Q72331358 | ||
| Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells | Q72391861 | ||
| Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin | Q72772880 | ||
| VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix | Q73119438 | ||
| Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor | Q73174689 | ||
| Angiogenesis in embryos and ischemic diseases | Q73447625 | ||
| Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors | Q24302929 | ||
| Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2 | Q24313613 | ||
| Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 | ||
| FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern | Q24561476 | ||
| Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3 | Q24564164 | ||
| Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons | Q24610347 | ||
| High molecular mass forms of basic fibroblast growth factor are initiated by alternative CUG codons | Q24621303 | ||
| Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis | Q24684263 | ||
| Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
| Transcriptional activation by tetracyclines in mammalian cells | Q28303934 | ||
| Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 | ||
| Mechanisms of angiogenesis | Q29547485 | ||
| Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo | Q29614729 | ||
| The biology of vascular endothelial growth factor | Q29615946 | ||
| Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid | Q29617640 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| What Is the Evidence That Tumors Are Angiogenesis Dependent? | Q29620029 | ||
| Angiogenic factors | Q29620582 | ||
| The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 | ||
| Long-term culture of capillary endothelial cells | Q34038077 | ||
| Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model | Q34125421 | ||
| A form of human basic fibroblast growth factor with an extended amino terminus | Q34184496 | ||
| Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis | Q34210479 | ||
| Mr 25,000 heparin-binding protein from guinea pig brain is a high molecular weight form of basic fibroblast growth factor | Q34339175 | ||
| Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology | Q34435505 | ||
| Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex | Q42820335 | ||
| Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells | Q43540195 | ||
| Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. | Q44393459 | ||
| Autocrinological role of basic fibroblast growth factor on tube formation of vascular endothelial cells in vitro | Q45279191 | ||
| Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor | Q46102175 | ||
| The NH2-terminal extension of high molecular weight bFGF is a nuclear targeting signal | Q47430427 | ||
| Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia | Q48072985 | ||
| Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor | Q48362283 | ||
| Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. | Q52245642 | ||
| Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. | Q54194832 | ||
| Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. | Q54195980 | ||
| Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. | Q55075615 | ||
| Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer | Q58212506 | ||
| Relation of neovascularisation to metastasis of non-small-cell lung cancer | Q59219829 | ||
| Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: A morphometric study | Q67466074 | ||
| Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro | Q67466166 | ||
| Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 | ||
| Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis | Q69639706 | ||
| Both normal and tumor cells produce basic fibroblast growth factor | Q70151344 | ||
| High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells | Q70175493 | ||
| Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract | Q70487576 | ||
| Prognostic value of vascular endothelial growth factor expression in gastric carcinoma | Q71018131 | ||
| The role of angiogenesis in tumor growth | Q34539790 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing | Q34582371 | ||
| Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix | Q34613112 | ||
| Molecular and biological properties of the vascular endothelial growth factor family of proteins | Q35313427 | ||
| The FGF family of growth factors and oncogenes | Q35335377 | ||
| Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. | Q35597273 | ||
| A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane | Q35818217 | ||
| Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro | Q35834090 | ||
| Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis | Q36219574 | ||
| Basic fibroblast growth factor is an extracellular matrix component required for supporting the proliferation of vascular endothelial cells and the differentiation of PC12 cells | Q36221277 | ||
| Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms. | Q36235250 | ||
| Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor | Q36682049 | ||
| Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: A trivial phenomenon or a novel secretion mechanism? | Q36715068 | ||
| Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells | Q36745687 | ||
| Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. | Q37357790 | ||
| Fibroblast growth factor 2 control of vascular tone | Q37362801 | ||
| Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells | Q37375977 | ||
| Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution | Q37381980 | ||
| Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner | Q37639452 | ||
| Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules | Q38345199 | ||
| Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb | Q39425647 | ||
| The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. | Q40241912 | ||
| Vascular permeability factor (VPF, VEGF) in tumor biology | Q40801255 | ||
| Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. | Q40822298 | ||
| Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. | Q41151821 | ||
| Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. | Q41168278 | ||
| Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. | Q41172786 | ||
| Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity | Q41292409 | ||
| Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. | Q41295542 | ||
| Biological roles of fibroblast growth factor-2. | Q41349632 | ||
| Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. | Q41481649 | ||
| Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant | Q41488146 | ||
| Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms | Q41588972 | ||
| Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. | Q41672018 | ||
| Multiple forms of bFGF: differential nuclear and cell surface localization | Q41705923 | ||
| Nuclear and cytoplasmic localization of different basic fibroblast growth factor species | Q41729091 | ||
| Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. | Q41940732 | ||
| Expression of basic fibroblast growth factor in normal human tissues. | Q41966344 | ||
| Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma | Q42050021 | ||
| Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor | Q42447438 | ||
| In situ detection of basic fibroblast growth factor by highly specific antibodies | Q42465684 | ||
| Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium | Q42477247 | ||
| Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer | Q42481577 | ||
| Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only | Q42495897 | ||
| Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle | Q42498198 | ||
| Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. | Q42805196 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| angiogenesis | Q539568 | ||
| P1104 | number of pages | 15 | |
| P304 | page(s) | 1659-1673 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Journal of Cell Biology | Q1524550 |
| P1476 | title | Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis | |
| P478 | volume | 141 |
| Q48207420 | "Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer. |
| Q37330610 | A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2). |
| Q52843117 | A biphasic endothelial stress-survival mechanism regulates the cellular response to vascular endothelial growth factor A. |
| Q47184569 | A clinical study of weining granules in the treatment of gastric precancerous lesions. |
| Q35757194 | A homeobox gene related to Drosophila distal-less promotes ovarian tumorigenicity by inducing expression of vascular endothelial growth factor and fibroblast growth factor-2 |
| Q52861322 | A molecular study of the t(4;14) in multiple myeloma. |
| Q34912686 | A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor |
| Q39197445 | A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs |
| Q50992929 | A single injection of protein-loaded coacervate-gel significantly improves cardiac function post infarction. |
| Q37296212 | AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR. |
| Q89791253 | Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy |
| Q34099797 | Activated STAT3 is a mediator and biomarker of VEGF endothelial activation |
| Q39961630 | Activation of the VEGFR1 chromatin domain: an angiogenic signal-ETS1/HIF-2alpha regulatory axis |
| Q51648646 | Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications |
| Q53729453 | Amelioration of diabetes in mice after single-donor islet transplantation using the controlled release of gelatinized FGF-2. |
| Q30480495 | An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis |
| Q30428010 | An engineered muscle flap for reconstruction of large soft tissue defects |
| Q36187754 | An integrated approach to quantitative modelling in angiogenesis research |
| Q41765103 | Analysis of risk factor and clinical characteristics of angiodysplasia presenting as upper gastrointestinal bleeding |
| Q33598141 | Angiogenesis in urological malignancy: prognostic indicator and therapeutic target |
| Q46700278 | Angiogenesis is repressed by ethanol exposure during chick embryonic development |
| Q37139109 | Angiogenesis-related pathways in the pathogenesis of ovarian cancer |
| Q35927935 | Angiogenic Potential of Cryopreserved Amniotic Membrane Is Enhanced Through Retention of All Tissue Components in Their Native State |
| Q28586566 | Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs |
| Q41812238 | Angiogenic synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in an in vitro quantitative microcarrier-based three-dimensional fibrin angiogenesis system |
| Q85055700 | Angiogenic therapy for cardiac repair based on protein delivery systems |
| Q36339410 | Angiopoietin-1 prevents severe bleeding complications induced by heparin-like drugs and fibroblast growth factor-2 in mice |
| Q36929784 | Angiopoietin-1 receptor Tie2 distinguishes multipotent differentiation capability in bovine coccygeal nucleus pulposus cells |
| Q35104246 | Anti-angiogenic agents for the treatment of brain tumors |
| Q38059807 | Anticancer steroids: linking natural and semi-synthetic compounds |
| Q44578123 | Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factors |
| Q93089068 | Application of Bioengineered Materials in the Surgical Management of Heart Failure |
| Q35155950 | Application of bladder acellular matrix in urinary bladder regeneration: the state of the art and future directions |
| Q36381376 | Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration |
| Q47233570 | Basic Fibroblast Growth Factor Protects Astrocytes Against Ischemia/Reperfusion Injury by Upregulating the Caveolin-1/VEGF Signaling Pathway |
| Q42047332 | Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1. |
| Q40156805 | Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats |
| Q90652600 | Bioactive Extracellular Matrix Scaffold Promotes Adaptive Cardiac Remodeling and Repair |
| Q35787037 | Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering |
| Q99578823 | Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration |
| Q42257831 | Bis-Retinoid A2E Induces an Increase of Basic Fibroblast Growth Factor via Inhibition of Extracellular Signal-Regulated Kinases 1/2 Pathway in Retinal Pigment Epithelium Cells and Facilitates Phagocytosis |
| Q51822480 | Bladder Regeneration by Bladder Acellular Matrix Combined with Sustained Release of Exogenous Growth Factor |
| Q26739893 | Blood vessel formation and function in bone |
| Q37524243 | Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling |
| Q30560161 | Bone morphogenetic protein-2/-4 upregulation promoted by endothelial cells in coculture enhances mouse embryoid body differentiation |
| Q54411096 | Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. |
| Q24804352 | CD44 in rheumatoid arthritis |
| Q38423895 | Cardiac fibroblast physiology and pathology |
| Q36801092 | Cell-cell signaling in the neurovascular unit |
| Q39951513 | Chemotherapeutic drugs and human tumor cells cytokine network |
| Q33784288 | Clinical applications of angiogenic growth factors and their inhibitors |
| Q84422578 | Clinical study of external application of Qiyu oil gauze for promoting post-operational healing in patients with anal fistula |
| Q38453467 | Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice |
| Q46106778 | Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis |
| Q35949632 | Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling |
| Q37463912 | Complexity of tumor vasculature in clear cell renal cell carcinoma |
| Q36187221 | Computational Screening of Tip and Stalk Cell Behavior Proposes a Role for Apelin Signaling in Sprout Progression. |
| Q21558516 | Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth |
| Q41778639 | Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer |
| Q26753299 | Cytokines in cancer drug resistance: Cues to new therapeutic strategies |
| Q39224317 | DJ-1 promotes angiogenesis and osteogenesis by activating FGF receptor-1 signaling. |
| Q41093104 | Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs |
| Q64095112 | Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice |
| Q88632326 | Delayed development of ossification centers in the tibia of prenatal and early postnatal MPS VII mice |
| Q46820538 | Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation |
| Q42316713 | Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway |
| Q40531799 | Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells |
| Q49544357 | Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer |
| Q33718137 | Diverse roles of the vasculature within the neural stem cell niche |
| Q37415307 | Dose-dependent response of FGF-2 for lymphangiogenesis |
| Q35747992 | Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668 |
| Q37499536 | Dual Therapeutic Action of a Neutralizing Anti-FGF2 Aptamer in Bone Disease and Bone Cancer Pain |
| Q24338434 | Early VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activity |
| Q40919536 | Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis |
| Q90229871 | Effect of Diosmin Administration in Patients with Chronic Venous Disorders on Selected Factors Affecting Angiogenesis |
| Q35711544 | Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice |
| Q53071922 | Effects of combinations of BMP-2 with FGF-2 and/or VEGF on HUVECs angiogenesis in vitro and CAM angiogenesis in vivo. |
| Q43189547 | Embryonic vasculogenesis and hematopoietic specification |
| Q54470556 | Enamel matrix derivative induces production of vascular endothelial cell growth factor in human gingival fibroblasts. |
| Q39332638 | Endothelial Progenitor Cells for the Vascularization of Engineered Tissues |
| Q27304564 | Endothelial Rictor is crucial for midgestational development and sustained and extensive FGF2-induced neovascularization in the adult |
| Q34218313 | Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. |
| Q50870947 | Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis. |
| Q35855631 | Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer |
| Q52099714 | Epicardium is required for the full rate of myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2 and its receptor, FGFR-1, but not for transmural myocardial patterning in the embryonic chick heart. |
| Q34116922 | Establishment of neutralizing rat monoclonal antibodies for fibroblast growth factor-2 |
| Q92403252 | Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model |
| Q54638974 | Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas. |
| Q73513451 | Expression of pituitary-tumour transforming gene in colorectal tumours |
| Q73708839 | Expression of the 37-kDa laminin binding protein in murine lung tumor cell correlates with tumor angiogenesis |
| Q36784736 | Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells |
| Q60954969 | Extracellular Vesicles Released by Human Induced-Pluripotent Stem Cell-Derived Cardiomyocytes Promote Angiogenesis |
| Q39214058 | FDA-Approved Oligonucleotide Therapies in 2017. |
| Q41979549 | FGF signaling preserves the integrity of endothelial adherens junctions |
| Q35572401 | FGF-dependent regulation of VEGF receptor 2 expression in mice |
| Q40625565 | FGF1 and VEGF Mediated Angiogenesis in KHT Tumor-Bearing Mice |
| Q36259512 | FGF2 gene activated matrices promote proliferation of bone marrow stromal cells |
| Q40807184 | FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network |
| Q28592971 | FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod |
| Q48169358 | Fas/FasL Complex Promotes Proliferation and Migration of Brain Endothelial Cells Via FADD-FLIP-TRAF-NF-κB Pathway |
| Q64056777 | Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis |
| Q33978027 | Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. |
| Q37603125 | Fibroblast Growth Factor Receptor 1 (FGFR1), Partly Related to Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Microvessel Density, is an Independent Prognostic Factor for Non-Small Cell Lung Cancer |
| Q92544513 | Fibroblast Growth Factor Receptor Signaling in Skin Cancers |
| Q24292720 | Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation |
| Q42831759 | Fibroblast growth factor 2 activation of stromal cell vascular endothelial growth factor expression and angiogenesis |
| Q38923517 | Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma |
| Q37129668 | Fibroblast growth factor regulation of neovascularization |
| Q28511544 | Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development |
| Q40257434 | Fibroblast growth factor-2 drives and maintains progressive corneal neovascularization following HSV-1 infection |
| Q40617929 | Fibroblast growth factor-2-mediated capillary morphogenesis of endothelial cells requires signals via Flt-1/vascular endothelial growth factor receptor-1: possible involvement of c-Akt |
| Q39282670 | Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment. |
| Q36510999 | Fibroblasts influence muscle progenitor differentiation and alignment in contact independent and dependent manners in organized co-culture devices. |
| Q53420593 | Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene. |
| Q47368100 | Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis |
| Q37178657 | G3139, an anti-Bcl-2 antisense oligomer that binds heparin-binding growth factors and collagen I, alters in vitro endothelial cell growth and tubular morphogenesis |
| Q50754479 | GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis. |
| Q58051574 | Gene Therapy Using Plasmid DNA Encoding VEGF164 and FGF2 Genes: A Novel Treatment of Naturally Occurring Tendinitis and Desmitis in Horses |
| Q39027588 | Gene delivery nanoparticles to modulate angiogenesis |
| Q40738783 | Gene expression profile in fibroblast growth factor 2-transformed endothelial cells |
| Q36196010 | Ghrelin Decreases Angiogenesis, HIF-1α and VEGF Protein Levels in Chronic Hypoxia in Lung Tissue of Male Rats |
| Q54536901 | Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase/Akt and beta-catenin/T-cell factor-dependent pathway in human endothelial cells. |
| Q28611472 | Growth factor activation in myocardial vascularization: therapeutic implications |
| Q37061103 | Growth factors and cell therapy in myocardial regeneration |
| Q41746417 | Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors |
| Q36291384 | High-throughput screening for bioactive molecules using primary cell culture of transgenic zebrafish embryos |
| Q61443821 | Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism |
| Q41722810 | Human three-dimensional fibroblast cultures express angiogenic activity |
| Q35129129 | Human urine-derived stem cells alone or genetically-modified with FGF2 Improve type 2 diabetic erectile dysfunction in a rat model. |
| Q49708073 | Identification of Basic Fibroblast Growth Factor as the Dominant Protector of Laminar Shear Medium from the Modified Shear Device in Tumor Necrosis Factor-α Induced Endothelial Dysfunction |
| Q53965626 | Immunoexpression of MMP-9, VEGF, and vWF in central and peripheral giant cell lesions of the jaws. |
| Q37572370 | Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. |
| Q47719363 | In vitro basic fibroblast growth factor (bFGF) delivery using an antithrombogenic 2-methacryloyloxyethyl phosphorylcholine (MPC) polymer coated with a micropatterned diamond-like carbon (DLC) film. |
| Q34648510 | In vitro inhibition of angiogenesis by antibodies directed against the 37kDa/67kDa laminin receptor |
| Q83348229 | In vitro study in stimulating the secretion of angiogenic growth factors of strontium-doped calcium polyphosphate for bone tissue engineering |
| Q43659656 | In vivo angiogenesis in normal and portal hypertensive rats: role of basic fibroblast growth factor and nitric oxide |
| Q64983871 | Inhibition of growth of canine-derived vascular endothelial cells by non-steroidal anti-inflammatory drugs and atrial natriuretic peptide. |
| Q34981750 | Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2 |
| Q35170697 | Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis. |
| Q38009655 | Insights into gene therapy for critical limb ischemia: the devil is in the details. |
| Q35949653 | Integrative signaling in angiogenesis. |
| Q36701444 | Interleukin-1β induces fibroblast growth factor 2 expression and subsequently promotes endothelial progenitor cell angiogenesis in chondrocytes. |
| Q40007223 | Intracellular trafficking of endogenous fibroblast growth factor-2. |
| Q42467807 | Involvement of metalloprotease-2 in the development of human brain microvessels |
| Q24632703 | Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer |
| Q34718345 | Junctional adhesion molecule-A regulates vascular endothelial growth factor receptor-2 signaling-dependent mouse corneal wound healing |
| Q52655388 | Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis. |
| Q42277371 | Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy |
| Q39251471 | LincRNa-p21: function and mechanism in cancer |
| Q47682626 | Localization of vascular endothelial growth factor in nontumorous human pituitaries |
| Q57817458 | Long Pentraxin-3 Modulates the Angiogenic Activity of Fibroblast Growth Factor-2 |
| Q34980366 | Loss of keratinocytic RXRα combined with activated CDK4 or oncogenic NRAS generates UVB-induced melanomas via loss of p53 and PTEN in the tumor microenvironment. |
| Q41268048 | Low Concentration of Sodium Butyrate from Ultrabraid+NaBu suture, Promotes Angiogenesis and Tissue Remodelling in Tendon-bones Injury |
| Q36843511 | MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts |
| Q35660360 | Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma |
| Q37596872 | Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation |
| Q73895265 | Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane |
| Q37164593 | Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization |
| Q88952347 | Mesenchymal Stem Cell Paracrine Factors in Vascular Repair and Regeneration |
| Q37679619 | MicroRNAs-role in lung cancer |
| Q39750443 | Modeling the early stages of vascular network assembly. |
| Q47418529 | Modeling the inhibition of breast cancer growth by GM-CSF. |
| Q92238951 | Modulation of Angiogenic Processes by the Human Gammaherpesviruses, Epstein-Barr Virus and Kaposi's Sarcoma-Associated Herpesvirus |
| Q40927116 | Modulation of cell growth and transformation by doxycycline-regulated FGF-2 expression in NIH-3T3 cells |
| Q61810261 | Molecular Network Basis of Invasive Pituitary Adenoma: A Review |
| Q50423780 | Molecular Regulation of Sprouting Angiogenesis |
| Q58551472 | Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review |
| Q34178900 | Molecular mechanisms of tumor angiogenesis and tumor progression |
| Q33887339 | Molecular mechanisms of vascular permeability in diabetic retinopathy |
| Q64063641 | Morphology-Dependent Host FGF-2 Response as a Potential Therapeutic Target |
| Q43679026 | Multiple growth factors regulate coronary embryonic vasculogenesis |
| Q38309443 | Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients |
| Q50131382 | Neuropilin-1 Mediated Arterial Differentiation of Murine Pluripotent Stem Cells |
| Q30490801 | Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. |
| Q33922875 | New paradigms for the treatment of cancer: the role of anti-angiogenesis agents |
| Q39357300 | Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species |
| Q81446261 | Normal patterning of the coronary capillary plexus is dependent on the correct transmural gradient of FGF expression in the myocardium |
| Q93082344 | Novel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane |
| Q34515646 | Novel diabetic mouse models as tools for investigating diabetic retinopathy |
| Q48342467 | Oligodendroglial fibroblast growth factor receptor 1 gene targeting protects mice from experimental autoimmune encephalomyelitis through ERK/AKT phosphorylation. |
| Q30490875 | Optical mapping of impulse propagation in engineered cardiac tissue |
| Q38748690 | Optimizing the host substrate environment for cardiac angiogenesis, arteriogenesis, and myogenesis |
| Q37267378 | PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting |
| Q33275971 | PPARalpha deficiency in inflammatory cells suppresses tumor growth |
| Q40714072 | Paracrine activation of extracellular signal-regulated kinase in a simple in vitro model of wounded osteoblasts |
| Q57456320 | Pathological processes activated by herpes simplex virus-1 (HSV-1) infection in the cornea |
| Q37381550 | Paths of FGFR-driven tumorigenesis |
| Q39305373 | Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients |
| Q37053858 | Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease |
| Q35562693 | Perlecan and tumor angiogenesis |
| Q33391125 | Phase I and pharmacokinetic study of TSU-68, a novel multiple receptor tyrosine kinase inhibitor, by twice daily oral administration between meals in patients with advanced solid tumors |
| Q34981292 | Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells |
| Q64103615 | Phytochemicals Targeting VEGF and VEGF-Related Multifactors as Anticancer Therapy |
| Q50091134 | Placental growth throughout the last two thirds of pregnancy in sheep: vascular development and angiogenic factor expression |
| Q33703845 | Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy |
| Q42153567 | Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear function |
| Q33675114 | Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation |
| Q35177011 | Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer |
| Q36228311 | Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis |
| Q64110061 | Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential |
| Q89843928 | Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors |
| Q46429748 | Rapamycin reduces VEGF expression in retinal pigment epithelium (RPE) and inhibits RPE-induced sprouting angiogenesis in vitro |
| Q42528044 | Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2. |
| Q36785331 | Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization. |
| Q53955419 | Release Kinetics and in vitro Bioactivity of Basic Fibroblast Growth Factor: Effect of the Thickness of Fibrous Matrices |
| Q58323579 | Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis |
| Q39221209 | Response of the cerebral vasculature following traumatic brain injury |
| Q40730311 | Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor |
| Q39068605 | Role of M2-like macrophage recruitment during angiogenic growth factor therapy |
| Q54487345 | Role of fibroblast growth factor signaling in vascular formation and maintenance: orchestrating signaling networks as an integrated system. |
| Q51941355 | Role of repulsive factors in vascularization dynamics. |
| Q27025540 | Roles of FGF signaling in stem cell self-renewal, senescence and aging |
| Q33899574 | S100A13 is a new angiogenic marker in human melanoma |
| Q50895931 | S1P Synergizes with Wall Shear Stress and Other Angiogenic Factors to Induce Endothelial Cell Sprouting Responses. |
| Q39350876 | SU6668, a multiple tyrosine kinase inhibitor, inhibits progression of human malignant pleural mesothelioma in an orthotopic model |
| Q37551794 | Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance |
| Q35990029 | Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model |
| Q37380465 | Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature |
| Q37400353 | Spatiotemporal tracking of cells in tissue-engineered cardiac organoids |
| Q36180591 | Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor |
| Q52632502 | Sprouty2 expression controls endothelial monolayer integrity and quiescence. |
| Q36845727 | Statistical platform to discern spatial and temporal coordination of endothelial sprouting. |
| Q46834835 | Structure Activity Relationship of Heparin Mimicking Polymer p(SS-co-PEGMA): Effect of Sulfonation and Polymer Size on FGF2-Receptor Binding |
| Q55472739 | Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. |
| Q46676094 | Subchoroidal Release of VEGF and bFGF Produces Choroidal Neovascularization in Rabbit |
| Q43933934 | Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma |
| Q41593699 | TGF-beta1 induces rearrangement of FLK-1-VE-cadherin-beta-catenin complex at the adherens junction through VEGF-mediated signaling. |
| Q42175314 | TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α. |
| Q36614139 | TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells |
| Q33912018 | Target molecules for anti-angiogenic therapy: from basic research to clinical trials |
| Q34062422 | Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo |
| Q37412392 | Targeted disruption of the Fgf2 gene does not affect vascular growth in the mouse ischemic hindlimb |
| Q28344662 | Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis |
| Q52624116 | Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A Comparison Study of Signalling Factors and Small Molecules. |
| Q44319291 | Temporal changes in regeneration-associated gene expression in cryopreserved rat vascular grafts |
| Q42561804 | Temporally expressed PDGF and FGF-2 regulate embryonic coronary artery formation and growth |
| Q34805055 | The Effect of Fibroblast Co-culture on In Vitro Maturation of Mouse Preantral Follicles |
| Q90232767 | The Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer |
| Q59335689 | The Platelet Response to Tissue Injury |
| Q37690651 | The Pleiotropic Role of L1CAM in Tumor Vasculature |
| Q36601812 | The Shc adaptor protein is critical for VEGF induction by Met/HGF and ErbB2 receptors and for early onset of tumor angiogenesis |
| Q38252537 | The angiogenic asset of soft tissue sarcomas: a new tool to discover new therapeutic targets. |
| Q40022803 | The angiogenic variation of skeletal site-specific human BMSCs from same alveolar cleft patients: a comparative study. |
| Q43202381 | The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts |
| Q33940874 | The effect of leptin on luteal angiogenic factors during the luteal phase of the estrous cycle in goats |
| Q47120527 | The effect of low intensity shockwave treatment (Li-SWT) on human myoblasts and mouse skeletal muscle |
| Q40875944 | The first peak of the UVB irradiation-dependent biphasic induction of vascular endothelial growth factor (VEGF) is due to phosphorylation of the epidermal growth factor receptor and independent of autocrine transforming growth factor alpha. |
| Q38208062 | The ins and outs of fibroblast growth factor receptor signalling. |
| Q34658478 | The pathogenesis of diabetic retinopathy: old concepts and new questions |
| Q38540713 | The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. |
| Q38840344 | The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production |
| Q37512303 | The role of fibroblast growth factors in tumor growth |
| Q78384186 | The role of fibroblast growth factors in vascular development |
| Q37308157 | The role of vascular endothelial growth factor in wound healing |
| Q36314802 | The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy |
| Q50048638 | Therapeutically targeting tumor microenvironment-mediated drug resistance in estrogen receptor-positive breast cancer. |
| Q44518833 | Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha |
| Q77359737 | Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate |
| Q73124809 | Tissue engineering |
| Q37386687 | Tissue-engineered endothelial cell layers on surface-modified Ti for inhibiting in vitro platelet adhesion. |
| Q36915712 | Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver. |
| Q48524593 | Transcriptomic analysis of gene cascades involved in protein kinase A and C signaling in the KGN line of human ovarian granulosa tumor cells†. |
| Q42562736 | Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis |
| Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
| Q34704214 | Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options |
| Q35786008 | Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor |
| Q38988571 | Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery |
| Q73787163 | Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF |
| Q33989013 | Ultrastructural immunolocalization of basic fibroblast growth factor in endothelial cells: morphologic evidence for unconventional secretion of a novel protein |
| Q91893478 | Up-regulation of pro-angiogenic pathways and induction of neovascularization by an acute retinal light damage |
| Q37004659 | VEGF Trap(R1R2) suppresses experimental corneal angiogenesis. |
| Q28375509 | VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism |
| Q48358455 | VEGF expression is developmentally regulated during human brain angiogenesis |
| Q35768578 | VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis |
| Q58765708 | VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis |
| Q52601468 | Vascular endothelial growth factor (VEGF-A) and fibroblast growth factor (FGF-2) as potential regulators of seasonal reproductive processes in male European bison (Bison bonasus, Linnaeus 1758). |
| Q52767251 | Vascular endothelial growth factor causally contributes to the angiogenic response upon ultraviolet B irradiation in vivo. |
| Q42130349 | Vascular endothelial growth factor expression and vascular density in oral squamous cell carcinoma (OSCC): A study on clinical and histopathologic significance |
| Q44319020 | Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells |
| Q35087955 | Vascular endothelial growth factor localization in the adult. |
| Q43850088 | Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells |
| Q47429370 | Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis |
| Q36807993 | Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenes |
| Q50773041 | Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. |
| Q33292668 | Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. |
| Q59400995 | Xueshuantong Injection (Lyophilized) Attenuates Cerebral Ischemia/Reperfusion Injury by the Activation of Nrf2–VEGF Pathway |
| Q38712092 | Zebrafish Caudal Haematopoietic Embryonic Stromal Tissue (CHEST) Cells Support Haematopoiesis |
| Q54600919 | [Advanced research of fibroblast growth factor receptor in non-small cell lung cancer]. |
| Q53677535 | [Angiogenic factors in external auditory canal cholesteatoma-fibroblast cell culture]. |
| Q83775208 | [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery] |
| Q40083516 | alpha-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling |
| Q36429702 | c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. |
| Q95847957 | siVEGF-loaded nanoparticle uptake by tumor-associated vascular endothelial cells for hepatocellular carcinoma |
Search more.